378 related articles for article (PubMed ID: 29391761)
1. Autoimmune liver disease-related autoantibodies in patients with biliary atresia.
Pang SY; Dai YM; Zhang RZ; Chen YH; Peng XF; Fu J; Chen ZR; Liu YF; Yang LY; Wen Z; Yu JK; Liu HY
World J Gastroenterol; 2018 Jan; 24(3):387-396. PubMed ID: 29391761
[TBL] [Abstract][Full Text] [Related]
2. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
5. Antilactoferrin antibodies in autoimmune liver disease.
Muratori L; Muratori P; Zauli D; Grassi A; Pappas G; Rodrigo L; Cassani F; Lenzi M; Bianchi FB
Clin Exp Immunol; 2001 Jun; 124(3):470-3. PubMed ID: 11472410
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases.
Roozendaal C; de Jong MA; van den Berg AP; van Wijk RT; Limburg PC; Kallenberg CG
J Hepatol; 2000 May; 32(5):734-41. PubMed ID: 10845659
[TBL] [Abstract][Full Text] [Related]
7. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.
Li BA; Liu J; Hou J; Tang J; Zhang J; Xu J; Song YJ; Liu AX; Zhao J; Guo JX; Chen L; Wang H; Yang LH; Lu J; Mao YL
World J Gastroenterol; 2015 Jan; 21(1):283-91. PubMed ID: 25574103
[TBL] [Abstract][Full Text] [Related]
10. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis.
Sobajima J; Ozaki S; Uesugi H; Osakada F; Inoue M; Fukuda Y; Shirakawa H; Yoshida M; Rokuhara A; Imai H; Kiyosawa K; Nakao K
Gut; 1999 Jun; 44(6):867-73. PubMed ID: 10323891
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.
Ohira H; Tojo J; Shinzawa J; Suzuki T; Miyata M; Nishimaki T; Kasukawa R
Fukushima J Med Sci; 1998 Dec; 44(2):83-92. PubMed ID: 10091380
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
[TBL] [Abstract][Full Text] [Related]
13. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).
Stinton LM; Bentow C; Mahler M; Norman GL; Eksteen B; Mason AL; Kaplan GG; Lindkvist B; Hirschfield GM; Milkiewicz P; Cheung A; Janssen HL; Fritzler MJ
PLoS One; 2014; 9(11):e112877. PubMed ID: 25397578
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody profile of primary sclerosing cholangitis.
Gur H; Shen G; Sutjita M; Terrberry J; Alosachie I; Barka N; Lin HC; Peter JB; Meroni PL; Kaplan M
Pathobiology; 1995; 63(2):76-82. PubMed ID: 8554703
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
[TBL] [Abstract][Full Text] [Related]
17. Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases.
Roozendaal C; Kallenberg CG
Hepatogastroenterology; 1999; 46(30):3034-40. PubMed ID: 10626156
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune hepatitis in the Alaska Native population: autoantibody profile and HLA associations.
Ferucci ED; Choromanski TL; Hurlburt KJ; Livingston S; Plotnik J; Manns MP; McMahon BJ; James JA
Liver Int; 2014 Sep; 34(8):1241-9. PubMed ID: 24939565
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune liver serology: current diagnostic and clinical challenges.
Bogdanos DP; Invernizzi P; Mackay IR; Vergani D
World J Gastroenterol; 2008 Jun; 14(21):3374-87. PubMed ID: 18528935
[TBL] [Abstract][Full Text] [Related]
20. Correlation of circulating endoglin with clinical outcome in biliary atresia.
Preativatanyou K; Honsawek S; Chongsrisawat V; Vejchapipat P; Theamboonlers A; Poovorawan Y
Eur J Pediatr Surg; 2010 Jul; 20(4):237-41. PubMed ID: 20383820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]